Will Lewis, Insmed CEO

In­smed plots up­com­ing med launch­es built on its first drug lessons and con­sumer play­book mar­ket­ing strate­gies

With its first drug launch in the books, In­smed is now fo­cus­ing on build­ing out a road map for up­com­ing prod­ucts – with an eye on con­sumer mar­ket­ing strate­gies.

For CEO Will Lewis, that means tap­ping con­sumer in­sights as ear­ly as pos­si­ble and de­vel­op­ing prod­ucts and pack­ag­ing that are in­tu­itive and easy to use. It al­so means trans­lat­ing those pa­tient ex­pe­ri­ences in­to cre­ative and atyp­i­cal bio­phar­ma mar­ket­ing, and in both cas­es, tak­ing a page from con­sumer mar­keters’ play­books.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.